作者投稿
专家审稿
编辑办公
邮件订阅
RSS
-
摘要:
目的 探讨胶原膜与碱性成纤维细胞生长因子(base fibroblast growth factor, bFGF)特异结合的人工生物补片作为主动脉瓣膜替代材料的可行性。 方法 健康杂种家犬10只随机分为对照组和实验组, 每组5只, 静脉全麻、腹主动脉阻断下分别使用仅浸泡磷酸盐缓冲液的胶原膜材料或特异结合bFGF的胶原膜材料作为人工瓣膜行腹主动脉腔内移植。于术后3个月利用超声心动图对人工瓣膜的功能进行评价, 于术后6个月取材观察人工瓣膜状况。 结果 术后3个月超声心动图检测人工瓣膜的功能在对照组和实验组之间无差别, 术后6个月对照组及实验组犬腹主动脉腔内的人工瓣膜均降解。 结论 胶原膜与bFGF特异结合的人工生物补片在体内的降解速率较快, 目前尚不能作为主动脉瓣膜良好的替代材料。 -
关键词:
- 人工生物补片 /
- 心脏瓣膜病 /
- 碱性成纤维细胞生长因子 /
- 胶原膜
Abstract:Objective To study the feasibility of artificial biologic patch made of collagen membranes loaded with collagen-binding base fibroblast growth factor (bFGF) as aortic valve replacement. Methods Ten healthy mongrel dogs were randomly divided into control group and experiment group (both n=5). Abdominal aorta replacement using artificial biologic patch made of collagen membranes loaded with collagen-binding bFGF (experiment group) or soaked with phosphate buffered saline (control group) was performed under general anesthesia and abdominal aorta blockage. Three months after the surgery, echocardiography was performed to evaluate the function of the artificial valve. Six months after the surgery, the condition of the artificial valve transplanted in the abdominal aorta was observed. Results No significant difference was found between the experiment group and the control group in function of the artificial valve evaluated by echocardiography 3 months after the surgery. The artificial valves entirely degraded 6 months after implanted into the abdominal aorta in both groups. Conclusion The degradation of artificial biologic patch made of collagen membrane loaded with collagen-binding bFGF in vivo is so fast that it is not a good alternative for replacement of the aortic valve. -
[1] Chan V, Jamieson WR, Germann E, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement[J]. J Thorac Cardiovasc Surg, 2006, 131:1267-1273. doi: 10.1016/j.jtcvs.2005.11.052 [2] Jamieson WR, von Lipinski O, Miyagishima RT, et al. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement[J]. J Thorac Cardiovasc Surg, 2005, 129:1301-1308. doi: 10.1016/j.jtcvs.2004.09.042 [3] Jamieson WR, Gudas VM, Burr LH, et al. Mitral valve disease:if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?[J]. Eur J Cardiothorac Surg, 2009, 35:104-110. doi: 10.1016/j.ejcts.2008.08.021 [4] Zhang J, Ding L, Zhao Y, et al. Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction[J]. Circulation, 2009, 119:1776-1784. doi: 10.1161/CIRCULATIONAHA.108.800565 [5] Gao J, Liu J, Gao Y, et al. A myocardial patch made of collagen membranes loaded with collagen-binding human vascular endothelial growth factor accelerates healing of the injured rabbit heart[J]. Tissue Eng Part A, 2011, 17:2739-2747. doi: 10.1089/ten.tea.2011.0105 [6] Feng C, Zhang C, Shao X, et al. Enhancement of nose-to-brain delivery of basic fibroblast growth factor for improving rat memory impairments induced by co-injection of β-amyloid and ibotenic acid into the bilateral hippocampus[J]. Int J Pharm, 2012, 423:226-234. doi: 10.1016/j.ijpharm.2011.12.008 [7] Yasuda Y, Koyama H, Tabata Y, et al. Controlled delivery of bFGF remodeled vascular network in muscle flap and increased perfusion capacity via minor pedicle[J]. J Surg Res, 2008, 147:132-137. doi: 10.1016/j.jss.2007.10.009 [8] Park CJ, Clark SG, Lichtensteiger CA, et al. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF[J]. Acta Biomater, 2009, 5:1926-1936. doi: 10.1016/j.actbio.2009.03.002 [9] Burdzińska A, Bartoszuk U, Orzechowski A. Preincubation with bFGF but not sodium ascorbate improves efficiency of autologous transplantation of muscle-derived cells into urethral wall[J]. Urology, 2009, 73:736-742. doi: 10.1016/j.urology.2008.11.024 [10] Lee H, Cusick RA, Browne F, et al. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices[J]. Transplantation, 2002, 73:1589-1593. doi: 10.1097/00007890-200205270-00011 [11] Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres[J]. J Biomed Mater Res A, 2003, 65:489-497. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=6ddc6c5e3885531d3d650dbf7aa999da -
下载:
点击查看大图
图(3)
计量
- 文章访问数: 136
- HTML全文浏览量: 35
- PDF下载量: 8
- 被引次数: 0
